Pharmaceutical
Intrance Medical Systems Inc., a U.S.-based, late stage development company established in 2018, is focused on developing and commercializing its novel drug/device combination for late-stage Parkinson’s disease in the U.S., Canada, LATAM, Japan, and Taiwan.